MARA Holdings
MARA
Lennar Corp
LEN
Adobe
ADBE
Apple
AAPL
Vale SA
VALE
US Stock MarketDetailed Quotes
VCYT Veracyte
- 33.840
- -1.690-4.76%
Close Feb 27 16:00 ET
- 34.340
- +0.500+1.48%
Post 18:35 ET
2.62BMarket Cap109.16P/E (TTM)
35.690High33.780Low1.59MVolume35.510Open35.530Pre Close54.67MTurnover2.06%Turnover Ratio109.16P/E (Static)77.50MShares47.31652wk High2.23P/B2.61BFloat Cap18.61052wk Low--Dividend TTM77.18MShs Float86.030Historical High--Div YieldTTM5.38%Amplitude4.210Historical Low34.413Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Veracyte Stock Forum
$Veracyte (VCYT.US)$
has options
nfa
The extensive validation of Veracyte's Decipher platform at ASCO GU 2025, supported by 17 abstracts and publication in Annals of Oncology, represents a significant strengthening of the company's market position in cancer diagnostics. The data demonstrates three important commercial advantages:
First, the Decipher Prostate test's ability to predict treatment response in the NRG Oncology/RTOG 0534 trial provides a clear clinical utility case for insura...
Revolutionary Cancer Test Results: Veracyte's Decipher Unlocks Personalized Treatment Success
Veracyte's Decipher Tests Dominate ASCO GU 2025 with Groundbreaking Cancer Detection Results
Clinical Study: Revolutionary Bladder Cancer Test Predicts Disease Progression with 33% Higher Accuracy
$ARK Innovation ETF (ARKK.US)$ :
Bought $Advanced Micro Devices (AMD.US)$ $DraftKings (DKNG.US)$ $Tempus AI (TEM.US)$
Sold $Unity Software (U.US)$ $Palantir (PLTR.US)$ $Twist Bioscience (TWST.US)$ $Veracyte (VCYT.US)$
By the way..
Palantir $PLTR is on fire this year
It's up over 109% YTD, just got included in the S&P500, and today Bank of America raised their price target to $50 a share
D. E. Shaw owns almost $500 million worth of shares, more than any...
No comment yet